110683-23-3 Usage
Uses
Used in Pharmaceutical Industry:
8-Amino-4-oxo-2-tetrazol-5-yl-4H-1-benzopyran is used as a potential therapeutic agent for various diseases due to its demonstrated pharmacological properties. Its anticancer activity makes it a candidate for the development of new cancer treatments, targeting different types of cancer cells.
Used in Anti-Inflammatory Applications:
In the field of inflammation management, 8-Amino-4-oxo-2-tetrazol-5-yl-4H-1-benzopyran is used as an anti-inflammatory agent, potentially alleviating symptoms and reducing the impact of inflammatory conditions on the body.
Used in Antimicrobial Applications:
8-Amino-4-oxo-2-tetrazol-5-yl-4H-1-benzopyran is utilized as an antimicrobial agent, showing promise in combating various types of bacteria and other microorganisms, which could be instrumental in the development of new antibiotics or antifungal agents.
Used in Neurodegenerative Disease Treatment:
In the medical field, particularly in neurology, 8-Amino-4-oxo-2-tetrazol-5-yl-4H-1-benzopyran is being studied for its potential role in treating neurodegenerative diseases, suggesting that it may have neuroprotective properties that could slow disease progression or alleviate symptoms.
Used in Drug Development:
8-Amino-4-oxo-2-tetrazol-5-yl-4H-1-benzopyran is employed as a key component in drug development, where its unique structure and pharmacological activities are leveraged to create novel therapeutic agents for a range of medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 110683-23-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,0,6,8 and 3 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 110683-23:
(8*1)+(7*1)+(6*0)+(5*6)+(4*8)+(3*3)+(2*2)+(1*3)=93
93 % 10 = 3
So 110683-23-3 is a valid CAS Registry Number.
110683-23-3Relevant academic research and scientific papers
New potent antagonists of leukotrienes C4 and D4. 1. Synthesis and structure-activity relationships
Nakai,Konno,Kosuge,Sakuyama,Toda,Arai,Obata,Katsube,Miyamoto,Okegawa,Kawasaki
, p. 84 - 91 (2007/10/02)
(p-Amylcinnamoyl)anthranilic acid (3a) had moderate antagonist activities against LTD4-induced smooth muscle contraction on guinea pig ileum and LTC4-induced bronchoconstriction in anesthetized guinea pigs. Modifications were made in the hydrophobic part (cinnamoyl moiety) and the hydrophilic part (anthranilate moiety) of 3a. A series of 8-(benzoylamino)-2-tetrazol-5-yl-1,4-benzodioxans and 8-(benzoylamino)-2-tetrazol-5-yl-4-oxo-4H-1-benzopyrans were revealed to be potent antagonists of leukotrienes C4 and D4. Among both series, ONO-RS-347 (18k) and ONO-RS411 (19h) were the most potent and orally active antagonists, respectively. Structure-activity relationships are discussed.
